COYA 8-K 2026-11-10

Coya Therapeutics, Inc. (COYA) 8-K dated 2026-11-10 — accession 0001193125-26-454473.

Coya Therapeutics, Inc. (COYA) is a biotechnology company listed on NASDAQ.

COYA: Coya Therapeutics Reports Third Quarter 2026 Financial Results and Prov…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.

Not investment advice. The COYA SEC hub lists recent forms. The stock page is the research view.